MSCs and their derivatives suppress RONS production, strengthen endogenous antioxidant defenses, preserve mitochondrial and endothelial-junction proteins, and reduce pro-inflammatory cytokine expression [22,23,24,25,26]
Always perform a patch test before using any new skin lightening product
Since every patients needs and goals are unique, the best way to know which peptides are right for you and what results you can expect is through a professional consultation
PubMed, Scopus, Embase, Web of Science and Cochrane Central library international databases were searched till September 2021

Its potential benefit has been posited due to its effect on improving mitochondrial function and the benefit seen as a neuroprotective agent in other clinical situations such as ischemic stroke, neurodegenerative diseases, and chemotherapy-induced encephalopathy.13 The authors of one article posited 2-3mg/kg/day divided into three doses for 7-10 days for newly infected patients could be a reasonable dose for initial studies.14 Given one meta-analysis reported that 12-35% of patients with long COVID suffered from cognitive impairment (colloquially called brain fog) and another found elevated brain injury markers during the acute phase of COVID-19, potential treatment and management strategies are in demand.13,14,15 Currently there are some trials evaluating the use of methylene blue for COVID-19, though, results and outcomes are not yet available.16,17 Brain injury and traumatic brain injury continue to be significant sources of morbidity and mortality and effective treatment options for prevention of acute and long-term damage are needed

Clinical experience with PRLX93936 underscores the ceiling for systemic dosing, as a phase I trial was terminated early when patients experienced severe, intolerable toxicity at very low doses (93), revealing an exceptionally narrow therapeutic index